Hongchang International Co. Ltd. Financials

HCIL

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 19 available years

Income Statement	MAR 2025	DEC 2024	DEC 2023	DEC 2022	DEC 2021
Revenues
Revenue	–	$3	$3	$0	$0
Cost of Revenue	–	$3	$3	$0	$0
Gross Profit	–	$0	$0	$0	$0
Operating Expenses
Selling & Marketing	–	$0	$0	$0	$0
General & Administrative	–	$1	$1	$0	–
Total Operating Expenses	–	$1	$1	$0	$0
Operating Income	–	-$0	-$0	-$0	-$0
Non-Operating
Net Interest Expense	–	$0	$0	–	–
Other Non-Operating Income (Expense)	–	-$0	$0	$0	-$0
EBT (Earnings Before Tax)	–	-$0	-$0	-$0	-$0
Income Tax Expense	–	-$0	-$0	–	–
Net Income
Net Income	–	-$0	-$0	-$0	-$0
Per Share Data
Revenue Per Share	–	$0.01	$0.01	$0.00	$0.00
EPS (Basic)	–	$0.00	-$0.00	$0.00	$0.00
EPS (Diluted)	–	$0.00	-$0.00	$0.00	$0.00
Weighted Avg Shares (Basic)	518.8M	518.8M	450.2M	1.03B	1.03B
Weighted Avg Shares (Diluted)	518.8M	518.8M	450.2M	1.03B	1.03B
Shares Outstanding	518.8M	518.8M	450.2M	1.03B	1.03B

SourceFinancial statements computed from the 10-Q filed 11 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Mar.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with HCIL

CompareIntrinsic value

YBGJYubo International Biotech Limited

$0.01+0.00%0

NXLNexalin Technology Inc.

$1.56+1.30%10

ENDVEndonovo Therapeutics Inc.

$0.00+0.00%15

POSCPositron Corporation

$1.67-1.76%0

GTHPGuided Therapeutics Inc.

$0.10-33.33%30

RDGLVivos Inc.

$0.04-1.64%40

PAVMPAVmed Inc.

$1.66-8.79%25

MBOTMicrobot Medical Inc.

$1.14+4.59%25

Spot a number that looks wrong? Check it in HCIL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HCIL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.